Article
Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patients.
Indian journal of cancer - 1 Jan 2000
Zanwar S, Noronha V, Joshi A, Patil V M, Chougule A, Kumar R, More S, Goud S, Janu A, Mahajan A, Prabhash K
Abstract excerpt
INTRODUCTION: The feasibility and success rate of repeat biopsy for epidermal growth factor receptor (EGFR) mutation-positive lung cancers that have progressed on tyrosine kinase inhibitors (TKIs) are varied and merits further assessment. MATERIALS AND METHODS: EGFR mutation-positive lung cancers were offered repeat biopsy upon progression on TKIs. Two groups of patients, first one on a clinical trial and second...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.